100
Views
11
CrossRef citations to date
0
Altmetric
Original Research

A Novel Clinical Radiomics Nomogram to Identify Crohn’s Disease from Intestinal Tuberculosis

, , , , , , , & show all
Pages 6511-6521 | Published online: 03 Dec 2021

References

  • Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/s0140-6736(17)32448-0
  • He C, Wang H, Yu C, et al. Alterations of gut microbiota in patients with intestinal tuberculosis that different from Crohn’s disease. Front Bioeng Biotechnol. 2021;9:673691. doi:10.3389/fbioe.2021.673691
  • Zhao Y, Xu M, Chen L, Liu Z, Sun X. Levels of TB-IGRA may help to differentiate between intestinal tuberculosis and Crohn’s disease in patients with positive results. Therap Adv Gastroenterol. 2020;13:1756284820922003. doi:10.1177/1756284820922003
  • Holt DQ, Moore GT, Strauss BJ, Hamilton AL, De Cruz P, Kamm MA. Visceral adiposity predicts post-operative Crohn’s disease recurrence. Aliment Pharmacol Ther. 2017;45(9):1255–1264. doi:10.1111/apt.14018
  • Pratap Mouli V, Munot K, Ananthakrishnan A, et al. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn’s disease. Aliment Pharmacol Ther. 2017;45(1):27–36. doi:10.1111/apt.13840
  • Lorenzetti R, Zullo A, Ridola L, et al. Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials. Ann Med. 2014;46(7):547–554. doi:10.3109/07853890.2014.941919
  • Mao R, Liao WD, He Y, et al. Computed tomographic enterography adds value to colonoscopy in differentiating Crohn’s disease from intestinal tuberculosis: a potential diagnostic algorithm. Endoscopy. 2015;47(4):322–329. doi:10.1055/s-0034-1391230
  • He Y, Zhu Z, Chen Y, et al. Development and validation of a novel diagnostic nomogram to differentiate between intestinal tuberculosis and Crohn’s disease: a 6-year Prospective Multicenter Study. Am J Gastroenterol. 2019;114(3):490–499. doi:10.14309/ajg.0000000000000064
  • Huang X, Liao WD, Yu C, et al. Differences in clinical features of Crohn’s disease and intestinal tuberculosis. World J Gastroenterol. 2015;21(12):3650–3656. doi:10.3748/wjg.v21.i12.3650
  • Zhao XS, Wang ZT, Wu ZY, et al. Differentiation of Crohn’s disease from intestinal tuberculosis by clinical and CT enterographic models. Inflamm Bowel Dis. 2014;20(5):916–925. doi:10.1097/mib.0000000000000025
  • Larsson G, Shenoy T, Ramasubramanian R, et al. Routine diagnosis of intestinal tuberculosis and Crohn’s disease in Southern India. World J Gastroenterol. 2014;20(17):5017–5024. doi:10.3748/wjg.v20.i17.5017
  • Mao R, Gao X, Zhu ZH, et al. CT enterography in evaluating postoperative recurrence of Crohn’s disease after ileocolic resection: complementary role to endoscopy. Inflamm Bowel Dis. 2013;19(5):977–982. doi:10.1097/MIB.0b013e318280758c
  • Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563–577. doi:10.1148/radiol.2015151169
  • Horvat N, Veeraraghavan H, Khan M, et al. MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology. 2018;287(3):833–843. doi:10.1148/radiol.2018172300
  • Zhang Y, He K, Guo Y, et al. A novel multimodal radiomics model for preoperative prediction of lymphovascular invasion in rectal cancer. Front Oncol. 2020;10:457. doi:10.3389/fonc.2020.00457
  • Huang YQ, Liang CH, He L, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157–2164. doi:10.1200/jco.2015.65.9128
  • Liu Z, Zhang XY, Shi YJ, et al. Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clin Cancer Res. 2017;23(23):7253–7262. doi:10.1158/1078-0432.Ccr-17-1038
  • Chen Y, Li H, Feng J, Suo S, Feng Q, Shen J. A novel radiomics nomogram for the prediction of secondary loss of response to infliximab in Crohn’s disease. J Inflamm Res. 2021;14:2731–2740. doi:10.2147/jir.S314912
  • Li X, Liang D, Meng J, et al. Development and validation of a novel computed-tomography enterography radiomic approach for characterization of intestinal fibrosis in Crohn’s disease. Gastroenterology. 2021. doi:10.1053/j.gastro.2021.02.027
  • Li H, Mo Y, Huang C, et al. An MSCT-based radiomics nomogram combined with clinical factors can identify Crohn’s disease and ulcerative colitis. Ann Transl Med. 2021;9(7):572. doi:10.21037/atm-21-1023
  • Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations. Gut. 2006;55 Suppl 1(Suppl1):i36–i58. doi:10.1136/gut.2005.081950c
  • Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management. J Crohns Colitis. 2010;4(1):28–62. doi:10.1016/j.crohns.2009.12.002
  • Logan VS. Anorectal tuberculosis. Proc R Soc Med. 1969;62(12):1227–1230.
  • Li T, Yang K, Stein JD, Nallasamy N. Gradient boosting decision tree algorithm for the prediction of postoperative intraocular lens position in cataract surgery. Transl Vis Sci Technol. 2020;9(13):38. doi:10.1167/tvst.9.13.38
  • Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389(10080):1741–1755. doi:10.1016/s0140-6736(16)31711-1
  • Veauthier B, Hornecker JR. Crohn’s disease: diagnosis and management. Am Fam Physician. 2018;98(11):661–669.
  • Jung Y, Hwangbo Y, Yoon SM, et al. Predictive factors for differentiating between Crohn’s disease and intestinal tuberculosis in Koreans. Am J Gastroenterol. 2016;111(8):1156–1164. doi:10.1038/ajg.2016.212
  • Seo H, Lee S, So H, et al. Temporal trends in the misdiagnosis rates between Crohn’s disease and intestinal tuberculosis. World J Gastroenterol. 2017;23(34):6306–6314. doi:10.3748/wjg.v23.i34.6306
  • Gupta A, Pratap Mouli V, Mohta S, et al. Antitubercular therapy given to differentiate Crohn’s disease from intestinal tuberculosis predisposes to stricture formation. J Crohns Colitis. 2020;14(11):1611–1618. doi:10.1093/ecco-jcc/jjaa091
  • Yu ZQ, Wang WF, Dai YC, Chen XC, Chen JY. Interleukin-22 receptor 1 is expressed in multinucleated giant cells: a study on intestinal tuberculosis and Crohn’s disease. World J Gastroenterol. 2019;25(20):2473–2488. doi:10.3748/wjg.v25.i20.2473
  • Zhang F, Xu C, Ning L, et al. Exploration of serum proteomic profiling and diagnostic model that differentiate Crohn’s disease and intestinal tuberculosis. PLoS One. 2016;11(12):e0167109. doi:10.1371/journal.pone.0167109
  • Patel B, Yagnik VD. Clinical and laboratory features of intestinal tuberculosis. Clin Exp Gastroenterol. 2018;11:97-103. doi:10.2147/ceg.S154235
  • Garg P, Goyal A, Yagnik VD, Dawka S, Menon GR. Diagnosis of anorectal tuberculosis by polymerase chain reaction, GeneXpert and histopathology in 1336 samples in 776 anal fistula patients. World J Gastrointest Surg. 2021;13(4):355–365. doi:10.4240/wjgs.v13.i4.355
  • Pulimood AB, Peter S, Ramakrishna B, et al. Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn’s disease. J Gastroenterol Hepatol. 2005;20(5):688–696. doi:10.1111/j.1440-1746.2005.03814.x
  • Li X, Liu X, Zou Y, et al. Predictors of clinical and endoscopic findings in differentiating Crohn’s disease from intestinal tuberculosis. Dig Dis Sci. 2011;56(1):188–196. doi:10.1007/s10620-010-1231-4
  • Makharia GK, Srivastava S, Das P, et al. Clinical, endoscopic, and histological differentiations between Crohn’s disease and intestinal tuberculosis. Am J Gastroenterol. 2010;105(3):642–651. doi:10.1038/ajg.2009.585